Medidata Launches Academic Board to Tackle Clinical Trial Inefficiencies — Medidata Solutions, Inc.

Event summary

Medidata introduced its Academic Site Advisory Board on June 22, 2026, at the AACI-CRI annual meeting in Chicago.
The board includes leaders from over a dozen prestigious research institutions, such as Mount Sinai Health System and Mayo Clinic.
The initiative aims to address operational challenges faced by academic medical centers (AMCs) in clinical trials.
AMCs represent more than half of Medidata’s user base and conduct 60-70% of all clinical trials worldwide.

The big picture

Medidata's new Academic Site Advisory Board is a strategic move to bridge the gap between clinical research and patient care, addressing inefficiencies in academic medical centers. This initiative underscores the growing importance of site-centric solutions in the clinical trials industry, where AMCs play a critical role. By leveraging direct input from leading research institutions, Medidata aims to drive technological advancements that could reshape the landscape of decentralized and hybrid clinical trials.

What we're watching

Execution Risk: Whether Medidata can effectively implement solutions derived from the board's insights to reduce workflow bottlenecks and administrative burdens.
Market Differentiation: How this initiative will position Medidata against competitors in addressing the unique needs of academic medical centers.
Patient-Centricity: The pace at which technological innovations from this collaboration enhance patient experiences and reduce trial burdens.